FDA Clearance Tracker · P980035-S272
ADVISA DR IPG, AT501 DDDRP PACING SYSTEM IPG
Last checked: Nov 20, 2026Latest source record: Mar 26, 2013 (this decision)Source: openFDAMethods & limitations
Decided
Mar 26, 2013
Approved
Time to decision
217 days
Received Aug 21, 2012. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P980035-S272
- Device name
- ADVISA DR IPG, AT501 DDDRP PACING SYSTEM IPG
- Applicant
- Medtronic, Inc.
- Applicant location
- Mounds View, MN
- Received
- Aug 21, 2012
- Decided
- Mar 26, 2013
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P980035
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR LABELING UPDATES TO INCORPORATE THE RESULTS OF THE RESPECT POST-APPROVAL STUDY FINAL REPORT, AND ADDITIONAL LABELING UPDATES.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.